
Bipolar disorder and substance use disorder co-occur at rates that make them one of the most challenging dual diagnosis combinations to treat. Roughly 40 to 60 percent of people with bipolar I disorder develop a substance use disorder at some point in their lives. The relationship is complex, the diagnosis is difficult when substance use is active, and the treatment requires specific expertise to get right.
This guide covers why bipolar disorder is frequently misdiagnosed alongside addiction, how manic and depressive phases each drive substance use, which medications are safe in recovery, what integrated treatment actually looks like, and what to look for in a dual-diagnosis program in Virginia.
CRISIS SUPPORT: If you or someone you love is experiencing suicidal thoughts, call or text 988 (Suicide and Crisis Lifeline) immediately. Available 24/7. Suicide risk is significantly elevated in patients with bipolar disorder, particularly during depressive phases and mixed episodes.
Diagnostic accuracy matters significantly for bipolar disorder because the treatment differs from unipolar depression. Common misdiagnosis patterns:
Diagnosed as major depression only. Depressive phases of bipolar disorder look similar to unipolar major depression. Without observation of manic or hypomanic episodes, the depression diagnosis is made and antidepressants are prescribed. This can trigger mania.
Diagnosed as substance-induced mood disorder. When substance use is active, mood symptoms are often attributed to the substances rather than an underlying bipolar disorder. This delays appropriate treatment.
Diagnosed as anxiety or ADHD. Hypomanic energy and irritability can be misread as anxiety or ADHD, particularly in young adults. Stimulant treatment for misdiagnosed ADHD can worsen bipolar disorder.
Diagnosed as personality disorder. The mood instability of bipolar disorder can be mistaken for borderline personality disorder, particularly in women. The treatment approaches differ significantly.
Accurate bipolar diagnosis often requires observation during sustained sobriety. Substance use can produce or mask mood symptoms, making diagnosis difficult until the person has been stable off substances for weeks to months. Some patients receive an accurate bipolar diagnosis only after treatment for substance use disorder allows the underlying mood pattern to become visible.
Manic and hypomanic episodes drive substance use through several mechanisms:
Substance use during mania can escalate quickly. What might be occasional use during stable periods can become daily heavy use during a manic episode. Manic-related use often produces the most severe consequences (arrests, financial ruin, medical emergencies) of the person's substance use history.
Bipolar depression drives relapse through patterns similar to unipolar depression, with additional complications:
Effective relapse prevention for bipolar and substance use disorder addresses mood stabilization as a foundation. Without stable mood, standard relapse prevention strategies work less effectively.
Mood stabilizers. The foundation of bipolar treatment. None have significant abuse potential.
Atypical antipsychotics. Approved for various phases of bipolar disorder. None have abuse potential.
Adjunctive medications. For specific symptoms.
MEDICATION SAFETY: Do not stop mood stabilizers abruptly. Sudden discontinuation can trigger severe manic or depressive episodes. Any medication changes should be coordinated with your prescribing psychiatrist. Antidepressants alone can trigger manic episodes in bipolar disorder.
Effective integrated treatment includes:
Coordinated psychiatric and addiction medicine. A single treatment team manages both conditions. Mood stabilizer dosing is coordinated with MAT for substance use disorder when applicable.
Mood stabilization before deep substance use work. Standard trauma or intensive therapy work is often delayed until mood is stabilized. Working on trauma during acute mania or severe depression produces poor outcomes.
Psychoeducation about bipolar disorder. Understanding the illness, recognizing early warning signs of mood episodes, and identifying triggers is central to treatment.
Circadian rhythm regulation. Sleep is one of the strongest bipolar mood regulators. Consistent sleep schedule, sleep hygiene, and treatment of sleep disorders are prioritized.
Family therapy. Bipolar disorder significantly affects family relationships. Family education and therapy improve outcomes for both conditions.
CBT for bipolar disorder. Modified cognitive behavioral therapy specifically for bipolar disorder addresses mood management, medication adherence, and relapse prevention.
Dialectical Behavior Therapy skills. Distress tolerance, emotion regulation, and interpersonal effectiveness skills are helpful for mood management.
Long-term outpatient care. Bipolar disorder is a lifelong condition. Ongoing psychiatric management continues indefinitely.
Questions to ask when evaluating programs:
If you or a loved one may have both bipolar disorder and a substance use disorder, integrated treatment matters significantly for long-term outcomes. Call a licensed Virginia dual-diagnosis provider today for a free confidential assessment. If suicidal thoughts are present, call or text 988 first. Bipolar disorder is manageable with proper treatment. Recovery from both conditions is possible with integrated care.
If you’re ready to explore your options — or just want to ask questions — reach out today. We’ll guide you with clarity, compassion, and confidence.
or message us directly through our website
You don’t have to figure this out alone. Let’s take the next step — together.
Very common. Roughly 40 to 60 percent of people with bipolar I disorder develop a substance use disorder at some point in their lives. Bipolar II disorder has similarly elevated rates. This makes bipolar disorder one of the most common dual diagnosis combinations. The relationship is complex, with mood episodes driving substance use and substance use worsening mood stability.
Several patterns produce misdiagnosis: bipolar depression looks like unipolar major depression without observation of manic or hypomanic episodes, active substance use produces mood symptoms attributed to substances rather than bipolar disorder, hypomanic energy can be misread as anxiety or ADHD, and mood instability can be mistaken for borderline personality disorder. Accurate diagnosis often requires observation during sustained sobriety.
Antidepressants alone can trigger manic episodes in bipolar disorder. This is why accurate diagnosis before starting depression treatment matters. When antidepressants are used in bipolar disorder, they are typically prescribed alongside a mood stabilizer (lithium, valproate, lamotrigine) to prevent triggered mania. Modern practice increasingly uses medications specifically approved for bipolar depression (quetiapine, lurasidone, lamotrigine) rather than SSRIs alone.
Mood stabilizers including lithium, valproate (Depakote), lamotrigine (Lamictal), and carbamazepine (Tegretol) are safe with no abuse potential. Atypical antipsychotics including quetiapine (Seroquel), olanzapine (Zyprexa), aripiprazole (Abilify), and lurasidone (Latuda) are approved for various phases and have no abuse potential. Benzodiazepines are avoided long-term due to abuse potential in patients with substance use disorder.
Manic and hypomanic episodes drive substance use through impulsivity, elevated energy, reduced need for sleep, grandiose thinking that reduces risk perception, racing thoughts and irritability driving use for relief, and reduced inhibitions. Alcohol is commonly used to slow racing thoughts. Cocaine and stimulants amplify manic energy. Substance use during mania can escalate quickly and produce the most severe consequences of the person's substance use history.
Bipolar depression drives relapse through severe depression driving self-medication, bipolar depression being more severe and treatment-resistant than unipolar depression, profound anhedonia making recovery activities feel impossible, elevated suicidal thoughts, and the knowledge that mood shifts are coming making stability feel elusive. Mixed episodes (depressive symptoms with manic energy) are particularly dangerous. Post-manic crashes also produce intense depression that drives substance use.
Integrated treatment includes coordinated psychiatric and addiction medicine with a single treatment team, mood stabilization before deep substance use work, psychoeducation about bipolar disorder, circadian rhythm regulation with consistent sleep, family therapy, CBT modified for bipolar disorder, Dialectical Behavior Therapy skills, and long-term outpatient care. Both conditions are treated simultaneously rather than sequentially, which consistently produces better outcomes.
Intensive treatment (PHP or IOP) typically lasts 30 to 90 days depending on severity. Mood stabilizers require weeks to reach full therapeutic effect and are typically continued indefinitely because bipolar disorder is a lifelong condition. MAT for substance use disorder is often long-term. Ongoing outpatient psychiatric management continues for life. Recovery is not a fixed timeline but an ongoing practice with regular psychiatric follow-up.
Yes. Virginia § 38.2-3412.1 requires insurance coverage of both mental health and substance use disorder treatment at parity with medical-surgical care. Virginia Medicaid (Cardinal Care), Anthem, UnitedHealthcare, Aetna, Tricare, and most major insurers cover integrated PHP, IOP, outpatient therapy, psychiatric medication management, and MAT for co-occurring bipolar and substance use disorder. Coverage details vary by plan.
What EAP covers for addiction, how to access benefits confidentially, using FMLA alongside EAP, and talking to HR about needing treatment in Virginia.
The link between grief and substance use, types of loss that trigger addiction, integrated dual treatment, and grief support resources in Hampton Roads Virginia.
How parental addiction affects children at different ages, their risk of developing addiction, warning signs, and Virginia resources for children of addicted parents.